Healthcare DIVE October 15, 2018
Andrew Dunn

The Trump administration will seek to require drugmakers to include list prices in direct-to-consumer television ads promoting their medicines in an aggressive policy proposal laid out by HHS Secretary Alex Azar in a Monday speech.

Under a proposed rule published Monday, pharmaceutical companies would be mandated to highlight wholesale acquisition costs in TV marketing campaigns for drug and biologic products for which payment is available through Medicare and Medicaid.

“Sometimes markets evolve on their own, but sometimes, it takes government to make the first move, to disrupt a broken system, and lay down new rules of the road,” Azar said, speaking at the National Academy of Medicine’s annual meeting. “You’ve heard today we’re willing to do just that....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, HHS, Pharma, Pricing / Spending, Provider
Will The White House’s Plan To Curb Drug Shortages Work?
Pharma Pulse 4/24/24: 5 Things You Should Know About Women's Health, Microsoft Makes Push Into Smaller AI Systems & more
New AI drug discovery powerhouse Xaira rises with $1B in funding
AI-enabled drug discovery company Xaira launches with $1B
25 most expensive hospital drugs

Share This Article